Skip to content
Search

Latest Stories

FP34C submission deadline extended to May 6

Pharmaceutical Services Negotiating Committee (PSNC) notifies pharmacy contractors that the FP34C submission deadline has been extended to end of May 6.

This month the contractors get an extra day, because of a bank holiday on May 2, to submit their FP34C declaration through Manage Your Service (MYS) Portal for NHS pharmaceutical services delivered in April 2022.


PSNC added: “Contractors must also dispatch their prescription bundle to the relevant pricing division at the NHSBSA by May 6. This extended submission deadline applies to any month where one or more bank holiday occurs during the first five days of the month.”

“Please note the requirement to submit electronic Claim Notification (CN) messages or Electronic Reimbursement Endorsement Messages (EREMs) within the first five days remains unchanged. CN messages and EREMs for prescriptions dispensed in April 2022 must continue to be submitted by May 5, 2022.”

The earlier advance payment date will remain as four working days from the extended submission deadline of the sixth day of the month. Therefore, to secure access to earlier advance payments on May 12, 2022, contractors must submit their April 2022 FP34Cs through the MYS no later than May 6, 2022.

Contractors who submit their April FP34C figures late through MYS (after 6 May) will NOT receive any earlier advance payments and instead, receive their advance payments in accordance with the normal payment timetable i.e. on June 1, 2022.

Last month, over 10,700 pharmacy contractors who declared their March 2022 FP34C submission figures through the MYS by April 5 2022 received their earlier advance payments on Monday April 11 2022 (circa 20 days earlier than the normal advance payment timetable).

However, around 350 contractors submitted their FP34C figures late (after April 5). These contractors will receive their advance payments in accordance with the normal payment timetable i.e. on May 1 2022.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less